← Eichor
Condition: Hepatitis B Chronic Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hepatitis B Chronic

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT04231565Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese
Phase N/A · 1 location(s) · Ruijin Hospital · NCT05870969Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus Infection
Phase N/A · 3 location(s) · Tam Anh Research Institute · NCT06638320HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients
Phase 1 · 1 location(s) · Changhai Hospital · NCT06885710A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
Phase 2 · 1 location(s) · Ausper Biopharma Co., Ltd. · NCT07069569VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
Phase 2 · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT06092333Research on Clinical Recovery and Maintenance Strategies for CHB
NA · 1 location(s) · Beijing Municipal Administration of Hospitals · NCT06803368Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
Phase N/A · 1 location(s) · Huashan Hospital · NCT04896255TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
Phase 1 · 1 location(s) · University of Maryland, Baltimore · NCT04843852Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study)
Phase 1 · 1 location(s) · Aarhus University Hospital · NCT06668727Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance
Phase N/A · 1 location(s) · Beijing Friendship Hospital · NCT06779864Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
Phase 4 · 1 location(s) · Taichung Veterans General Hospital · NCT03933384Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B
Phase N/A · 1 location(s) · Taichung Veterans General Hospital · NCT05583006Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
Phase 4 · 1 location(s) · Mercy Medical Center · NCT04588077A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B
Phase N/A · 5 location(s) · Tongji Hospital · NCT06525909A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease
Phase N/A · 1 location(s) · Qin Ning · NCT05255978Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of D
Phase N/A · 2 location(s) · University of Oxford · NCT06658782Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]
Phase 2 · 1 location(s) · University Health Network, Toronto · NCT06216470A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults
Phase 1 · 1 location(s) · Chimivac INC · NCT07059403A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone
Phase 2 · 1 location(s) · Fujian Shengdi Pharmaceutical Co., Ltd. · NCT06425341SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
Phase 4 · 1 location(s) · Chinese University of Hong Kong · NCT06364930Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)
Phase N/A · 18 location(s) · Arbutus Biopharma Corporation · NCT06277037A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants
Phase 1 · 2 location(s) · Ausper Biopharma Co., Ltd. · NCT07511218Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）
NA · 1 location(s) · Qing XIe · NCT06323681Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic H
Phase N/A · 1 location(s) · Minghui Li · NCT06696664A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis
Phase 3 · 1 location(s) · Beijing Continent Pharmaceutical Co, Ltd. · NCT07343778Assessment of Treatment Adherence and Associated Factors in Chronic HepB Patients Supported by HBVCare
NA · 2 location(s) · Institute of Gastroenterology and Hepatology, Vietnam · NCT07540637Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)
Phase 4 · 1 location(s) · Humanity & Health Medical Group Limited · NCT03792919TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate
Phase 1/Phase 2 · 6 location(s) · Michael Hoelscher · NCT06513286Hospital-Based Management of Patients With Chronic Hepatitis B Virus Infection
Phase N/A · 3 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT06966908
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.